Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers

Infection and Immunity

Volumn 69, Issue 12, 2001, Pages 7453-7460

  Pompeu, M M L ^a   Brodskyn, C ^a   Teixeira, M J ^a   Clarencio, J ^a   Van Weyenberg, J ^a   Coelho, I C B ^a   Cardoso, S A ^a   Barral, A ^a   Barral Netto, M ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; LEISHMANIA; LEISHMANIASIS; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROMASTIGOTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; FORECASTING; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; MALE; PROTOZOAN VACCINES; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; VACCINATION;

EID: 0035189086     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.12.7453-7460.2001     Document Type: Article

References (37)

1. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice
2. Controlled field trials of a vaccine against New World cutaneous leishmaniasis
3. The epidemiology of cutaneous leishmaniasis in subtropical Ecuador
4. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis
5. Transforming growth factor-beta in leishmanial infection: A parasite escape mechanism
6. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10
7. Macrophage deactivation by interleukin 10
8. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients
9. Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro
10. Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro
11. Cell mediated immunity in American cutaneous and mucosal leishmaniasis
12. Detection of cytokine with labeled antibodies
13. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection
14. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
15. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major
16. Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: A potential immunoregulatory role for CD8+ T cells
17. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania
18. Immunity to intracellular bacteria
19. Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals
20. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine
21. Tumour necrosis factor (TNF alpha) in leishmaniasis. I.TNF alpha mediates host protection against cutaneous leishmaniasis
22. Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil
23. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis
24. Gamma interferon response in secondary. Leishmania major infection: Role of CD8+ T cells
25. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells
26. Vaccination of humans against cutaneous leishmaniasis: Cellular and humoral immune responses
27. Selection of a skin test antigen for American visceral leishmaniasis
28. Cytokine profile and pathology in human leishmaniasis
29. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis
30. Naive human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages
31. Leishmania: Naive human T cells sensitized with promastigote antigen and IL-12 develop into potent Th1 and CD8(+) cytotoxic effectors
32. Leishmania major-specific CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice
33. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma
34. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages
35. Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals
36. Rapidly fatal leishmaniasis in resistant c57bl/6 mice lacking tnf
37. A heritable defect in IL-12 signaling in B10.Q/J mice. II. Effect on acute resistance to Toxoplasma gondii and rescue by IL-18